2026 Lipid Guidelines Use PREVENT Scores to Tailor Therapy
TL;DR Summary
The 2026 American dyslipidemia guideline endorses PREVENT-ASCVD risk equations to guide primary prevention therapy and suggests considering lipid-lowering treatment for adults at intermediate risk based on a 10-year PREVENT-ASCVD risk, with additional considerations for borderline risk and for patients with moderate subclinical atherosclerosis, aiming to lower LDL cholesterol.
- New Lipid Guidelines Redefine Risk Categories, Loop in People as Young as 30 MedPage Today
- Earlier Cholesterol Testing Can Reduce Heart Attacks and Strokes, New Guideline Says The New York Times
- A cholesterol test you've never heard of is now recommended to prevent heart disease NPR
- Millions more people may need to start cholesterol-lowering medications as young as their 30s. Here’s why CNN
- ACC, AHA Release New Clinical Guideline For Managing Dyslipidemia American College of Cardiology
Reading Insights
Total Reads
0
Unique Readers
4
Time Saved
7 min
vs 7 min read
Condensed
97%
1,386 → 48 words
Want the full story? Read the original article
Read on MedPage Today